Kezar Life Sciences (KZR) Earnings Date, Estimates & Call Transcripts → Mysterious Gold Leverage Just Announced (From Stansberry Research) (Ad) Free KZR Stock Alerts $0.79 -0.01 (-1.42%) (As of 04:32 PM ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaSustainability Earnings SummaryUpcoming Earnings DateMay. 9EstimatedActual EPS (Mar. 14) -$0.35 Beat By $0.04 Consensus EPS (Mar. 14) -$0.39 Get Kezar Life Sciences Earnings AlertsEnter your email address below to receive the latest news and earnings results for KZR and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueKZR Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.KZR Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Stansberry ResearchMysterious Gold Leverage Just AnnouncedWorld's biggest multibillionaire investor group is buying THIS by the tons Most folks have completely missed the fact that there's one group of investors so powerful they're literally buying ONE THING by the tons… Stacking it in their locked vaults on pallets in record numbers.Find out what it is and see how you can get in with just a few dollars. Kezar Life Sciences Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20242($0.34)($0.28)($0.31)Q2 20242($0.27)($0.26)($0.27)Q3 20242($0.26)($0.24)($0.25)Q4 20242($0.26)($0.21)($0.24)FY 20248($1.13)($0.99)($1.06)KZR Earnings Date and InformationKezar Life Sciences last announced its earnings results on March 14th, 2024. The reported ($0.35) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.39) by $0.04. Kezar Life Sciences has generated ($1.41) earnings per share over the last year (($1.41) diluted earnings per share). Earnings for Kezar Life Sciences are expected to grow in the coming year, from ($1.26) to ($1.25) per share. Kezar Life Sciences has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, May 9th, 2024 based off prior year's report dates.Read More Kezar Life Sciences Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 5/9/2024Estimated)------- 3/14/2024Q4 2023($0.39)($0.35)+$0.04($0.26)--11/13/2023Q3 2023($0.36)($0.32)+$0.04($0.32)$0.50 million$7.00 million8/10/2023Q2 2023($0.33)($0.34)($0.01)($0.34)--5/11/2023Q1 2023($0.28)($0.31)($0.03)($0.31)--3/14/2023Q4 2022($0.24)($0.25)($0.01)($0.25)--11/10/2022Q3 2022($0.26)($0.25)+$0.01($0.25)-- Get the Latest News and Ratings for KZR and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Kezar Life Sciences and its competitors with MarketBeat's FREE daily newsletter. 8/11/2022Q2 2022($0.27)($0.25)+$0.02($0.25)--5/12/2022Q1 2022($0.29)($0.26)+$0.03($0.26)-- 3/17/2022Q4 2021($0.29)($0.25)+$0.04($0.25)--11/9/2021Q3 2021($0.26)($0.28)($0.02)($0.28)--8/12/2021Q2 2021($0.26)($0.25)+$0.01($0.25)--5/12/2021Q1 2021($0.24)($0.25)($0.01)($0.25)-- Kezar Life Sciences Earnings - Frequently Asked Questions When is Kezar Life Sciences's earnings date? Kezar Life Sciences has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, May 9th, 2024 based off last year's report dates. Learn more on KZR's earnings history. Did Kezar Life Sciences beat their earnings estimates last quarter? In the previous quarter, Kezar Life Sciences (NASDAQ:KZR) reported ($0.35) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.39) by $0.04. Learn more on analysts' earnings estimate vs. KZR's actual earnings. How much revenue does Kezar Life Sciences generate each year? Kezar Life Sciences (NASDAQ:KZR) has a recorded annual revenue of $7 million. How much profit does Kezar Life Sciences generate each year? Kezar Life Sciences (NASDAQ:KZR) has a recorded net income of -$101.87 million. KZR has generated -$1.41 earnings per share over the last four quarters. What is Kezar Life Sciences's EPS forecast for next year? Kezar Life Sciences's earnings are expected to grow from ($1.26) per share to ($1.25) per share in the next year. More Earnings Resources from MarketBeat Related Companies: Vaxxinity Earnings Reneo Pharmaceuticals Earnings Homology Medicines Earnings Immuneering Earnings Checkpoint Therapeutics Earnings HCW Biologics Earnings SCYNEXIS Earnings Eagle Pharmaceuticals Earnings Gain Therapeutics Earnings Lantern Pharma Earnings Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: GE Aerospace is Ready for Liftoff After Strong EarningsTaiwan Semiconductor Earnings: AI Dominance and Future OutlookCSX Co.: The Railroad Powering Ahead with an Earnings Beat What's Driving Tesla Lower Ahead of its Earnings?Blackrock vs. State Street: Earnings in a Volatile MarketWhat to Expect From the Q1 Earnings Reporting SeasonLululemon Stock Implodes Post Earnings, Guidance Muted This page (NASDAQ:KZR) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe A.I. story nobody is telling you (Read ASAP)TradeSmithHe Is Giving Away BitcoinCrypto Swap Profitstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyThe only accurate crypto trading system I know …Weiss RatingsBitcoin Rockets To Record High But Buy THIS InsteadParadigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Kezar Life Sciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
